Literature DB >> 31969102

Delivery Efficacy Differences of Intravenous and Intraperitoneal Injection of Exosomes: Perspectives from Tracking Dye Labeled and MiRNA Encapsulated Exosomes.

Xueying Zhou1,2, Zhelong Li1,2, Wenqi Sun1,2, Guodong Yang2, Changyang Xing1, Lijun Yuan1.   

Abstract

BACKGROUND: Exosomes are cell-derived nanovesicles that play vital roles in intercellular communication. Recently, exosomes are recognized as promising drug delivery vehicles. Up till now, how the in vivo distribution of exosomes is affected by different administration routes has not been fully understood.
METHODS: In the present study, in vivo distribution of exosomes following intravenous and intraperitoneal injection approaches was systemically analyzed by tracking the fluorescence-labeled exosomes and qPCR analysis of C. elegans specific miRNA abundance delivered by exosomes in different organs.
RESULTS: The results showed that exosomes administered through tail vein were mostly taken up by the liver, spleen and lungs while exosomes injected intraperitoneally were more dispersedly distributed. Besides the liver, spleen, and lungs, intraperitoneal injection effectively delivered exosomes into the visceral adipose tissue, making it a promising strategy for obesity therapy. Moreover, the results from fluorescence tracking and qPCR were slightly different, which could be explained by systemic errors.
CONCLUSION: Together, our study reveals that different administration routes cause a significant differential in vivo distribution of exosomes, suggesting that optimization of the delivery route is prerequisite to obtain rational delivery efficiency in detailed organs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Exosomes; administration route; efficiency; in vivo delivery; intraperitoneal injection; intravenous injection.

Mesh:

Substances:

Year:  2020        PMID: 31969102     DOI: 10.2174/1567201817666200122163251

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  6 in total

1.  Exosome-mediated improvement in membrane integrity and muscle function in dystrophic mice.

Authors:  Ling Leng; Xue Dong; Xianjun Gao; Ning Ran; Mengyuan Geng; Bingfeng Zuo; Yingjie Wu; Wei Li; Hua Yan; Gang Han; HaiFang Yin
Journal:  Mol Ther       Date:  2020-12-15       Impact factor: 11.454

2.  Brown adipose tissue-derived exosomes mitigate the metabolic syndrome in high fat diet mice.

Authors:  Xueying Zhou; Zhelong Li; Meihao Qi; Ping Zhao; Yunyou Duan; Guodong Yang; Lijun Yuan
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

3.  Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds.

Authors:  Jinghuan Huang; Muyu Yu; Wenjing Yin; Bo Liang; Ang Li; Jingfeng Li; Xiaolin Li; Shichang Zhao; Fang Liu
Journal:  Bioact Mater       Date:  2021-02-20

4.  Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment.

Authors:  Te Bu; Zhelong Li; Ying Hou; Wenqi Sun; Rongxin Zhang; Lianbi Zhao; Mengying Wei; Guodong Yang; Lijun Yuan
Journal:  Theranostics       Date:  2021-10-25       Impact factor: 11.556

Review 5.  Nanoengineering facilitating the target mission: targeted extracellular vesicles delivery systems design.

Authors:  Haoyue Song; Xiaohang Chen; Yujia Hao; Jia Wang; Qingpeng Xie; Xing Wang
Journal:  J Nanobiotechnology       Date:  2022-09-29       Impact factor: 9.429

6.  Th2 Cytokines Increase the Expression of Fibroblast Growth Factor 21 in the Liver.

Authors:  Seul-Gi Kang; Seong-Eun Lee; Min-Jeong Choi; Joon-Young Chang; Jung-Tae Kim; Ben-Yuan Zhang; Yea-Eun Kang; Ju-Hee Lee; Hyon-Seung Yi; Minho Shong
Journal:  Cells       Date:  2021-05-24       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.